September 23, 2025 - 03:37

The Trump administration's proposal to increase the H-1B visa application fee to an unprecedented $100,000 has raised alarms among businesses in the technology sector. Hiba Anver, a partner at Erickson Immigration Group, argues that such a significant fee hike could pose serious challenges for both employers and prospective workers.
During a discussion on "Bloomberg Tech," Anver highlighted the potential repercussions of this policy change, emphasizing that it may deter highly skilled foreign talent from seeking employment in the United States. The H-1B visa program has been a vital avenue for tech companies to fill skill gaps in the workforce, and an exorbitant fee could lead to a shortage of qualified professionals in critical areas.
Employers may find it increasingly difficult to justify the costs associated with hiring international talent, which could ultimately impact innovation and competitiveness in the tech industry. As the proposal garners attention, many are left wondering how it will reshape the landscape of employment in the sector.
October 28, 2026 - 23:36
CSX Works Through Tech Outage as Security Team Confirms No CyberattackCSX is working through a technology outage that began Tuesday, with the company`s security team confirming the disruption was not a cyberattack and that no data breach occurred, according to a...
October 28, 2026 - 06:35
The Human Side of Patient CRM Upgrades: Four Choices Tech Cannot SolveModernizing a patient relationship management system is often framed as a software problem, but the hardest parts are not technical. Jaymin Sutarwala of United Therapeutics argues that four key...
October 27, 2026 - 19:33
SPOOKY SPECTACULAR - GATEWAY HEADS-UP MAFIA 2026 GRAND FINALETwo days. More than 360 cars. Nearly $30,000 in payouts. One weekend that will not be forgotten anytime soon. Some races are good. Some are memorable. Then there are weekends that remind everyone...
October 27, 2026 - 00:50
Aptar Pharma Expands Pulmonary Delivery Capabilities with Pulmotree AcquisitionAptar Pharma, a division of AptarGroup Inc., has acquired Pulmotree, a life sciences company based in Munich, Germany. The move strengthens the company`s position in pulmonary drug delivery...